# BIOLOGICAL THERAPEUTICS PRODUCT DEVELOPMENT SUBJECT MATTER EXPERT CONSULTING SERVICES TO SUPPORT THE DEVELOPMENT OF CELL AND GENE THERAPY PRODUCTS

> **NIH NIH N02** · — · 2024 · $6,000

## Abstract

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.

## Key facts

- **NIH application ID:** 11211258
- **Project number:** 75N95024P00328-0-0-1
- **Recipient organization:** —
- **Principal Investigator:** —
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $6,000
- **Award type:** —
- **Project period:** 2024-06-15 → 2025-06-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11211258

## Citation

> US National Institutes of Health, RePORTER application 11211258, BIOLOGICAL THERAPEUTICS PRODUCT DEVELOPMENT SUBJECT MATTER EXPERT CONSULTING SERVICES TO SUPPORT THE DEVELOPMENT OF CELL AND GENE THERAPY PRODUCTS (75N95024P00328-0-0-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11211258. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*